Skip to main content
NYSE:BSX

Boston Scientific Stock Forecast, Price & News

$41.55
-0.06 (-0.14 %)
(As of 05/14/2021 12:00 AM ET)
Add
Compare
Today's Range
$41.54
$42.04
50-Day Range
$37.92
$44.24
52-Week Range
$32.99
$44.63
Volume4.40 million shs
Average Volume9.24 million shs
Market Capitalization$59.04 billion
P/E Ratio15.92
Dividend YieldN/A
Beta0.87
30 days | 90 days | 365 days | Advanced Chart
Receive BSX News and Ratings via Email

Sign-up to receive the latest news and ratings for Boston Scientific and its competitors with MarketBeat's FREE daily newsletter.


Boston Scientific logo

About Boston Scientific

Boston Scientific Corp. engages in the development, manufacture and marketing of medical devices that are used in interventional medical specialties. It operates through the following segments: Rhythm and Neuro, Cardiovascular and MedSurg. The Rhythm and Neuro segment develops implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities. The Cardiovascular segment comprises of technologies or diagnosing and treating coronary artery disease and other cardiovascular disorders including structural heart conditions. The MedSurg segment focuses on Endoscopy, which provides devices to diagnose and treat a broad range of gastrointestinal and pulmonary conditions with innovative and invasive technologies. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Equipment
SectorMedical
CUSIP10113710
Phone(508) 683-4000
Employees36,000
Year Founded1979

Sales & Book Value

Annual Sales$10.74 billion
Cash Flow$2.75 per share
Book Value$9.96 per share

Profitability

Net Income$4.70 billion

Debt

Price-To-Earnings

Miscellaneous

Outstanding Shares1,420,911,000
Market Cap$59.04 billion
Next Earnings Date8/4/2021 (Estimated)
OptionableOptionable

Social Links


MarketRank

Overall MarketRank

2.18 out of 5 stars

Medical Sector

27th out of 2,039 stocks

Surgical & Medical Instruments Industry

2nd out of 168 stocks

Analyst Opinion: 3.4Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 3.1 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Boston Scientific (NYSE:BSX) Frequently Asked Questions

Is Boston Scientific a buy right now?

17 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Boston Scientific in the last twelve months. There are currently 4 hold ratings, 12 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Boston Scientific stock.
View analyst ratings for Boston Scientific
or view top-rated stocks.

What stocks does MarketBeat like better than Boston Scientific?

Wall Street analysts have given Boston Scientific a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Boston Scientific wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Boston Scientific's next earnings date?

Boston Scientific is scheduled to release its next quarterly earnings announcement on Wednesday, August 4th 2021.
View our earnings forecast for Boston Scientific
.

How were Boston Scientific's earnings last quarter?

Boston Scientific Co. (NYSE:BSX) announced its quarterly earnings data on Tuesday, April, 27th. The medical equipment provider reported $0.37 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of $0.31 by $0.06. The medical equipment provider had revenue of $2.75 billion for the quarter, compared to the consensus estimate of $2.62 billion. Boston Scientific had a trailing twelve-month return on equity of 11.77% and a net margin of 36.59%. The business's quarterly revenue was up 8.2% on a year-over-year basis. During the same period in the prior year, the firm posted $0.28 EPS.
View Boston Scientific's earnings history
.

How has Boston Scientific's stock price been impacted by Coronavirus (COVID-19)?

Boston Scientific's stock was trading at $33.86 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, BSX shares have increased by 22.7% and is now trading at $41.55.
View which stocks have been most impacted by COVID-19
.

What guidance has Boston Scientific issued on next quarter's earnings?

Boston Scientific issued an update on its FY 2021 earnings guidance on Wednesday, May, 5th. The company provided EPS guidance of 1.530-1.600 for the period, compared to the Thomson Reuters consensus estimate of $1.540. The company issued revenue guidance of $11.50 billion-$11.80 billion, compared to the consensus revenue estimate of $11.43 billion.

What price target have analysts set for BSX?

17 equities research analysts have issued 12-month price targets for Boston Scientific's stock. Their forecasts range from $43.00 to $52.00. On average, they anticipate Boston Scientific's stock price to reach $46.53 in the next year. This suggests a possible upside of 12.0% from the stock's current price.
View analysts' price targets for Boston Scientific
or view top-rated stocks among Wall Street analysts.

Who are Boston Scientific's key executives?

Boston Scientific's management team includes the following people:
  • Michael F. Mahoney, Chairman, President & Chief Executive Officer (LinkedIn Profile)
  • Edward F. Mackey, Executive Vice President-Global Operations (LinkedIn Profile)
  • Daniel J. Brennan, Chief Financial Officer & Executive Vice President (LinkedIn Profile)
  • Jodi Eddy, SVP, Chief Information & Digital Officer (LinkedIn Profile)
  • Ian T. Meredith, Global Chief Medical Officer & Executive VP (LinkedIn Profile)

What is Michael F. Mahoney's approval rating as Boston Scientific's CEO?

947 employees have rated Boston Scientific CEO Michael F. Mahoney on Glassdoor.com. Michael F. Mahoney has an approval rating of 98% among Boston Scientific's employees. This puts Michael F. Mahoney in the top 20% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of Boston Scientific's key competitors?

What other stocks do shareholders of Boston Scientific own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Boston Scientific investors own include NVIDIA (NVDA), Alibaba Group (BABA), Intel (INTC), AT&T (T), CVS Health (CVS), The Walt Disney (DIS), Bank of America (BAC), Advanced Micro Devices (AMD), Visa (V) and salesforce.com (CRM).

What is Boston Scientific's stock symbol?

Boston Scientific trades on the New York Stock Exchange (NYSE) under the ticker symbol "BSX."

Who are Boston Scientific's major shareholders?

Boston Scientific's stock is owned by a number of retail and institutional investors. Top institutional investors include BlackRock Inc. (9.20%), Massachusetts Financial Services Co. MA (5.82%), Primecap Management Co. CA (2.89%), Bollard Group LLC (2.21%), Artisan Partners Limited Partnership (1.63%) and Geode Capital Management LLC (1.46%). Company insiders that own Boston Scientific stock include Arthur C Butcher, Daniel J Brennan, David A Pierce, Desiree Ralls-Morrison, Eric Francis Yves Thepaut, Halliday Hamish, Jeffrey B Mirviss, Jodi Euerle Eddy, John Bradley Sorenson, Joseph Michael Fitzgerald, Maulik Nanavaty, Scott Olson, Wendy Carruthers, Williamson Scott and Xin Warren Wang.
View institutional ownership trends for Boston Scientific
.

Which institutional investors are selling Boston Scientific stock?

BSX stock was sold by a variety of institutional investors in the last quarter, including Prudential Financial Inc., BlackRock Inc., Assenagon Asset Management S.A., Caisse DE Depot ET Placement DU Quebec, Jennison Associates LLC, Federated Hermes Inc., TCW Group Inc., and OMERS ADMINISTRATION Corp. Company insiders that have sold Boston Scientific company stock in the last year include Arthur C Butcher, Daniel J Brennan, David A Pierce, Jeffrey B Mirviss, John Bradley Sorenson, Joseph Michael Fitzgerald, Maulik Nanavaty, Scott Olson, and Wendy Carruthers.
View insider buying and selling activity for Boston Scientific
or view top insider-selling stocks.

Which institutional investors are buying Boston Scientific stock?

BSX stock was bought by a variety of institutional investors in the last quarter, including Massachusetts Financial Services Co. MA, Parnassus Investments CA, Neuberger Berman Group LLC, Artisan Partners Limited Partnership, Primecap Management Co. CA, Standard Life Aberdeen plc, Ownership Capital B.V., and MUFG Securities EMEA plc.
View insider buying and selling activity for Boston Scientific
or or view top insider-buying stocks.

How do I buy shares of Boston Scientific?

Shares of BSX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Boston Scientific's stock price today?

One share of BSX stock can currently be purchased for approximately $41.55.

How much money does Boston Scientific make?

Boston Scientific has a market capitalization of $59.04 billion and generates $10.74 billion in revenue each year. The medical equipment provider earns $4.70 billion in net income (profit) each year or $1.58 on an earnings per share basis.

How many employees does Boston Scientific have?

Boston Scientific employs 36,000 workers across the globe.

Does Boston Scientific have any subsidiaries?

The following companies are subsidiares of Boston Scientific: 34 Biomedical Merger Corp., 9357-1867 Quebec Inc., Acurate Industria e Comercio Ltda., Advanced Bionics, Advanced Stent Technologies, American Medical Systems, American Medical Systems Europe B.V., Apama Medical, Apama Medical Inc., Asthmatx, Atritech, Augmenix, Augmenix Inc., Augmenix K.K., BSC International Medical Trading (Shanghai) Co. Ltd., BSC Medical Device Technology (Shanghai) Co. Ltd., BTG, BTG Australasia Pty Ltd, BTG Europe B.V., BTG IM Holdings Ltd., BTG International (Holdings) Limited, BTG International Asia Limited, BTG International Canada Inc., BTG International Germany GmbH, BTG International Healthcare Inc., BTG International Healthcare LLC, BTG International Healthcare Limited, BTG International Inc., BTG International Limited, BTG Limited, BTG Management Services Limited, BTG Medikal Limited Sirketi, Bard Electrophysiology, Barosense, Biocompatibles Inc., Biocompatibles International Limited, Biocompatibles UK Limited, Boston Scientific (Malaysia) Sdn. Bhd., Boston Scientific (South Africa) Proprietary Limited, Boston Scientific (Thailand) Ltd., Boston Scientific (UK) Limited, Boston Scientific AG, Boston Scientific Argentina S.A., Boston Scientific Asia Pacific Pte. Ltd., Boston Scientific Benelux NV, Boston Scientific Canada Limited, Boston Scientific Ceska republika s.r.o., Boston Scientific Chile SpA, Boston Scientific Colombia Limitada, Boston Scientific Comercial de Costa Rica BSCR S.R.L., Boston Scientific Far East B.V., Boston Scientific Gesellschaft m.b.H., Boston Scientific Group plc, Boston Scientific Hellas S.A., Boston Scientific Hong Kong Limited, Boston Scientific Iberica S.A., Boston Scientific India Private Limited, Boston Scientific International B.V., Boston Scientific International Finance Limited, Boston Scientific International S.A., Boston Scientific Israel Ltd., Boston Scientific Japan K.K., Boston Scientific Korea Co. Ltd., Boston Scientific Lebanon SAL, Boston Scientific Limited, Boston Scientific Ltd., Boston Scientific Medical Device, Boston Scientific Medical Device Limited, Boston Scientific Medizintechnik GmbH, Boston Scientific Middle East FZ-LLC, Boston Scientific Middle East SAL, Boston Scientific Nederland B.V., Boston Scientific Neuromodulation Corporation, Boston Scientific New Zealand Limited, Boston Scientific Nordic AB, Boston Scientific Peru S.A.C., Boston Scientific Philippines Inc., Boston Scientific Polska Sp. z o.o., Boston Scientific Portugal - Dispositivos Medicos Lda, Boston Scientific Pty Ltd, Boston Scientific Romania S.R.L., Boston Scientific S.A.S., Boston Scientific S.p.A., Boston Scientific Scimed, Boston Scientific Scimed Inc., Boston Scientific Services Private Limited, Boston Scientific TIP Gerecleri Limited Sirketi, Boston Scientific Technology & Engineering Services Private Limited, Boston Scientific Uruguay S.A., Boston Scientific Vietnam Company Limited, Boston Scientific de Costa Rica S.R.L., Boston Scientific de Mexico S.A. de C.V., Boston Scientific del Caribe Inc., Boston Scientific do Brasil Ltda., Bravo Bidco Limited, BridgePoint Medical, Cameron Health, Cardiac Pacemakers Inc., Cardiac Pathways Corp, Catheter Innovations, Claret Medical, Claret Medical Inc., Cosman Medical, Cosman Medical LLC, CryoCor, Cryterion Medical, Cryterion Medical Inc., Cryterion Medical Ireland Limited, EKOS LLC, EMcision, EMcision International Inc., EP Technologies, EP Technologies Inc., Electron Acquisition Corporation, EndoChoice, EndoChoice Holdings Inc., EndoChoice Inc., EndoChoice Innovation Center Ltd., EndoChoice Israel Ltd., Endotex, Enteric Medical Technologies, Galil Medical Inc., Galil Medical Ltd., Galil Medical UK Limited, Guidant, Guidant Delaware Holding Corporation, Guidant Europe NV, Guidant Puerto Rico B.V., Hong Kong Medtech Trading Limited, Intelect Medical, Millipede, Millipede Inc., NXT Merger Corp., Notebook Merger Sub Ltd., Novate Medical Limited, NxThera, NxThera Inc., PT Boston Scientific Indonesia, PneumRx GmbH, PneumRx LLC, PneumRx Liimited, Protherics Medicines Development B.V., Protherics Medicines Development Limited, Protherics UK Limited, Provensis Limited, RMI Acquisition Corp., Remon Medical Technologies, Rhythmia Medical, Robert S. Smith M.D. Inc., Roxwood Medical Inc., SNS Merger Corp, Sadra Medical, Sadra Medical Inc., Securus Medical Group, Securus Medical Group Inc., Special K Merger Corp., StarMedTec, Stream Enterprises LLC, Symetis, Symetis SA, Target Therapeutics, Target Therapeutics Inc., The LumenR Tissue Retractor System, Veniti, Veniti Inc., VertiFlex, Vertiflex Inc., Vessix Vascular, Xlumena, Zuma Investment Pty Ltd, iogyn, nVision Medical, and nVision Medical Corporation.

When was Boston Scientific founded?

Boston Scientific was founded in 1979.

What is Boston Scientific's official website?

The official website for Boston Scientific is www.bostonscientific.com.

Where are Boston Scientific's headquarters?

Boston Scientific is headquartered at 300 BOSTON SCIENTIFIC WAY, MARLBOROUGH MA, 01752.

How can I contact Boston Scientific?

Boston Scientific's mailing address is 300 BOSTON SCIENTIFIC WAY, MARLBOROUGH MA, 01752. The medical equipment provider can be reached via phone at (508) 683-4000 or via email at [email protected]


This page was last updated on 5/15/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.